The relationship of depression and stressors to immunological assays: A meta-analytic review

Brain, Behavior, and Immunity

Volumn 15, Issue 3, 2001, Pages 199-226

  Zorrilla, Eric P ^a   Luborsky, Lester ^a   McKay, James R ^a   Rosenthal, Robert ^a   Houldin, Arlene ^a   Tax, Anne ^a   McCorkle, Ruth ^a   Seligman, David A ^a   Schmidt, Kelly ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Depression; Immunological assays; Meta analysis of measures; Stressors

Indexed keywords

ACUTE PHASE RESPONSE; ADULT; CELL PROLIFERATION; CLINICAL TRIAL; CYTOTOXIC T LYMPHOCYTE; DEPRESSION; FEMALE; HUMAN; HUMAN CELL; IMMUNOASSAY; LEUKOCYTOSIS; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; META ANALYSIS; NATURAL KILLER CELL; PRIORITY JOURNAL; REPRODUCIBILITY; REVIEW; SAMPLING; T LYMPHOCYTE ACTIVATION;

EID: 0035161111     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1006/brbi.2000.0597     Document Type: Review

References (210)

1. A controlled study of cellular immune function in affective disorders before and during somatic therapy
2. Lymphocyte function in major depression
3. Serum antibodies to Epstein-Barr virus in patients with major depressive disorder
4. PHA-stimulated cellular immune function and T-lymphocyte subsets in major depressive disorders
5. The state of leukocyte adhesiveness/aggregation in the peripheral blood is more sensitive than the white blood cell count for the detection of acute mental stress
6. The state of leukocyte adhesiveness/aggregation in the peripheral blood: A new and independent marker of mental stress
7. Lymphocyte subset and cellular immune responses to a brief experimental stressor
8. Stress, cortisol, and lymphocyte subpopulations
9. The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations
10. Immune parameters in a population of institutionalized elderly subjects: Influence of depressive disorders and endocrinological correlations
11. Evaluation of immune parameters in depressed patients
12. Chronic stress affects immunologic but not cardiovascular responsiveness to acute psychological stress in humans
13. Effects of beta-adrenergic blockade on immunologic and cardiovascular changes induced by mental stress
14. Cellular immunity in depressed, conduct disorder, and normal adolescents: Role of adverse life events
15. Effects of experimental psychological stress on distribution and function of peripheral blood cells
16. Influence of life stress on immunological reactivity to mild psychological stress
17. Effects of experimental psychological stress on T-lymphocytes and NK cells in man: An exploratory study
18. Heterogeneity in neuroendocrine and immune responses to brief psychological stressors as a function of autonomic cardiac activation
19. Depression, immunocompetence, and prostaglandins of the E series
20. Reduced natural killer cell cytotoxicity in depression but not in schizophrenia
21. Antibody and cell-mediated immunity to herpes simplex virus in psychotic depression
22. Effects of acute stress on lymphocyte beta 2-adrenoceptors in white males
23. A power primer
24. Psychological stress, immunity, and upper respiratory infections
25. Psychological stress and susceptibility to the common cold
26. Impaired mitogen-induced lymphocyte responses and the hypothalamic pituitary-adrenal axis in depressive disorders
27. Depressed mood and development of cancer
28. Mitogen-stimulated lymphocyte proliferation and pituitary hormones in major depression
29. Plasma beta-endorphin and natural killer cell activity in major depression: A preliminary study
30. Cellular immunity and the hypothalamic-pituitary axis in major affective disorder: A preliminary study
31. Neutrophilia and lymphopenia in major mood disorders
32. A critical appraisal of mitogen-induced lymphocyte proliferation in depressed patients
33. Polymorphonuclear (PMN) elastase levels in depressive disorders
34. Relationship of daily hassles, uplifts, and major life events to health status
35. Cytokine production and lymphocyte transformation during stress
36. Exemplification of a method for scaling life events: The PERI life events scale
37. Aberrations in lymphocyte subpopulations and function during psychological stress
38. Neopterin measurement provides evidence of altered cell-mediated immunity in patients with depression, but not with schizophrenia
39. Brief uncontrollable stress and psychological parameters influence human plasma concentrations of IgM and complement component C3
40. Circulating natural killer cell phenotypes in men and women with major depression: Relation to cytotoxic activity and severity of depression
41. Stress-associated reductions in cytotoxic T lymphocytes and natural killer cells in asymptomatic HIV infection
42. Major depression and immunity: Preliminary evidence of decreased natural killer cell populations
43. Changes of immunological parameters in healthy subjects under examination stress
44. Stress-induced reduction in the rat mixed lymphocyte reaction is due to macrophages and not changes in T cell phenotypes
45. Psychological stress-induced modulation of interleukin 2 receptor gene expression and interleukin 2 production in peripheral blood leukocytes
46. Stress, loneliness, and changes in herpesvirus latency
47. Stress-related impairments in cellular immunity
48. Stress-associated changes in plasma immunoglobulin levels
49. Stress and the memory T-cell response to the Epstein-Barr virus in healthy medical students
50. Stress-related immune suppression: Health implications
51. Stress depresses interferon production by leukocytes concomitant with a decrease in natural killer cell activity
52. Psychological factors & immunity; preliminary report
53. Neuroendocrine measures and lymphocyte subsets in depressive illness: Influence of a clinical interview concerning life experiences
54. Immunological responses of breast cancer patients to behavioral interventions
55. Impairment of lymphocyte activities in depressed aged subjects
56. Effects of examination stress on some cellular immunity functions
57. A rating scale for depression
58. Blood-cerebrospinal fluid barrier dysfunction for high molecular weight proteins in Alzheimer disease and major depression: Indication for disease subsets
59. Evidence of blood-cerebrospinal fluid-barrier impairment in a subgroup of patients with dementia of the alzheimer type and major depression: A possible indicator for immunoactivation
60. Natural killer cell activity and MMPI scores of a cohort of college students
61. Depression and immunity: A meta-analytic review
62. Stress and immunity in humans: A meta-analytic review
63. Cardiovascular reactivity and the course of immune response to an acute psychological stressor
64. Biochemical correlates of in vivo cell-mediated immune dysfunction in patients with depression: A preliminary report
65. Impaired in vivo immune responses in patients with melancholia
66. The social readjustment rating scale
67. Changes in immune and psychological measures as a function of anticipation and reaction to news of HIV-1 antibody status
68. Major depressive disorder, alcoholism, and reduced natural killer cell cytotoxicity
69. Life events, depressive symptoms, and immune function
70. Life events, depression natural killer cell activity
71. Impaired natural killer cell activity during bereavement
72. Depression and reduced natural killer cytotoxicity: A longitudinal study of depressed patients and control subjects
73. Reduction of immune function in life stress and depression
74. Low natural killer cytotoxicity in major depression
75. Influence of perceived psychological stress and distress on antibody response to low dose rDNA hepatitis B vaccine
76. Academic stress, power motivation, and decrease in secretion rate of salivary secretory immunoglobulin A
77. Academic stress, social support, and secretory immunoglobulin A
78. Haematological changes during acute mental stress
79. Elevated levels of acute phase plasma proteins in major depression
80. Temperament and allergic symptoms
81. Explanatory style and cell-mediated immunity in elderly men and women
82. Evidence that the effect of physical exercise on NK cell activity is mediated by epinephrine
83. Psychological and immunological predictors of genital herpes recurrence
84. Repeated bereavement, depressed mood, and immune parameters in HIV seropositive and seronegative gay men
85. Spousal caregivers of dementia victims: Longitudinal changes in immunity and health
86. Marital quality, marital disruption and immune function
87. Psychosocial modifiers of immunocompetence in medical students
88. Chronic stress and immunity in family caregivers of Alzheimer's disease victims
89. Modulation of cellular immunity in medical students
90. Marital discord and immunity in males
91. Urinary cortisol levels, cellular immunocompetency, and loneliness in psychiatric inpatients
92. Short-term immunological effects of induced emotion
93. Depression, cortisol, and immune function
94. Depression, hypothalamic-pituitary adrenocortical activity, and lymphocyte function
95. Lymphocyte mitogenesis, immunoglobulin and complement levels in depressed patients and normal controls
96. Natural killer cell activity in depressive illness: Preliminary report
97. Impaired lymphocyte function in depressive illness
98. Changes of immunoregulatory cells induced by psychological and physical stress: Relationship to plasma catecholamines
99. Unaltered monocyte function in patients with major depression before and after three months of antidepressive therapy
100. Immunoglobulins, autoantibodies and other serum protein fractions in psychiatric disorders
101. Elevated levels of prostaglandin E2 and thromboxane B2 in depression
102. Depressed mood and development of cancer
103. Stressful events, dysphoric mood, and immune responsiveness
104. The efficacy of psychological, educational, and behavioral treatment: Confirmation from meta-analysis
105. Stress, adaptation, and immunity: Studies in humans
106. Life change stress, psychiatric symptoms, and natural killer cell activity
107. Comparison of in vivo and in vitro glucocorticoid sensitivity in depression: Relationship to the dexamethasone suppression test
108. Evidence for an immune response in major depression: A review and hypothesis
109. Antiphospholipid, antinuclear, Epstein-Barr and cytomegalovirus antibodies, and soluble interleukin-2 receptors in depressive patients
110. Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1β and soluble interleukin-2 receptor production
111. Acute phase proteins in schizophrenia, mania and major depression: Modulation by psychotropic drugs
112. Alterations in plasma dipeptidyl peptidase IV enzyme activity in depression and schizophrenia: Effects of antidepressants and antipsychotic drugs
113. Lower serum dipeptidyl peptidase IV activity in treatment resistant major depression: Relationships with immune-inflammatory markers
114. Evidence for a systemic immune activation during depression: Results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining
115. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression
116. Plasma-soluble interleukin-2 and translenin receptor in schizophrenia and major depression
117. Disturbances in acute phase plasma proteins during melancholia: Additional evidence for the presence of an inflammatory process during that illness
118. Relationships between increased haptoglobin plasma levels and activation of cell-mediated immunity in depression
119. Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: Further evidence for an immune response
120. 1-antitrypsin, haptoglobin, ceruloplasmin and lower retinol binding protein plasma levels during depression: Further evidence for the existence of an inflammatory response during that illness
121. The monocyte-T-lymphocyte hypothesis of major depression
122. Immune disorders in depression: Higher T helper/T suppressor-cytotoxic cell ratio
123. A significantly increased number and percentage of B cells in depressed subjects: Results of flow cytometric measurements
124. Significantly increased expression of T-cell activation markers (interleukin-2 and HLA-DR) in depression: Further evidence for an inflammatory process during that illness
125. Neutrophil chemotaxis, phagocytosis, and superoxide release in depressive illness
126. A study on the blunted natural killer cell activity in severely depressed patients
127. Leukocytosis, monocytosis and neutrophilia: Hallmarks of severe depression
128. Increased serum interleukin-1-receptor-antagonist concentrations in major depression
129. Lower serum L-tryptophan availability in depression as a marker of a more generalized disorder in protein metabolism
130. Psychoneuroimmunology: The interface between behavior, brain, and immunity
131. Immune cell imbalance in major depressive and panic disorders
132. Stability of individual differences in cellular immune responses to acute psychological stress
133. Neutrophil and monocyte phagocytosis in depressed patients
134. Stressed power motivation, sympathetic activation, immune function, and illness
135. The effect of motivational arousal through films on salivary immunoglobulin A
136. The effect of an academic examination on salivary norepinephrine and immunoglobulin levels
137. Depression and the development of cancer: A meta-analysis
138. Life events, social support, and immune response in elderly individuals
139. Assessing aspects of object relations associated with immune function: Development of the affiliative trust-mistrust coding system
140. Stress, social support, coping resources, and immune status in elderly women
141. Lymphocyte subset redistribution in response to acute experimental stress: Effects of gender, ethnicity, hypertension, and the sympathetic nervous system
142. Enumerative immune changes following acute stress: Effect of the menstrual cycle
143. Microstress, mood, and natural killer-cell activity
144. Investigations of the cellular immunity during depression and the free interval: Evidence for an immune activation in affective psychosis
145. Immune reactivity, morbidity, and mortality of elderly humans
146. Association of lack of mitogen-induced lymphocyte proliferation with increased mortality in the elderly
147. Patients at risk for AIDS-related opportunistic infections: Clinical manifestations and impaired gamma interferon production
148. Immunological changes in young and old adults during brief laboratory stress
149. The effects of the opiate antagonist naloxone on measures of cellular immunity during rest and brief psychological stress
150. Rapid changes in cellular immunity following a confrontational role-play stressor
151. Increased soluble interleukin-2 receptor concentrations in suicide attempters
152. 1-acid glycoprotein, a putative endogenous inhibitor of the tritiated imipramine binding site, in depressed patients
153. Reduced natural killer cell activity in major depression: Neuroendocrine implications
154. Salivary prostaglandin concentrations: Possible state indicators for major depression
155. Increased level of salivary prostaglandins in patients with major depression
156. Stress, emotion, and human immune function
157. Abnormal zymosan-induced neutrophil chemiluminescence as a marker of depression
158. Psychological factors, immunologic activation, and disease activity in rheumatoid arthritis
159. Relationship of stress, distress, and the immunologic response to a recombinant hepatitis B vaccine
160. Lymphocyte subsets associated with major depression and dysthymia: Modification by antidepressant treatment
161. Variations of lymphocyte subsets associated with stress in depressive populations
162. From health locus of control to immune control: Internal locus of control has a buffering effect on natural killer cell activity decrease in major depression
163. Writing meta-analytic reviews
164. Psychophysiological, neuroendocrine and cellular immune reactions under psychological stress
165. Changes of natural killer cells during acute psychological stress
166. Major depressive disorder and immunity
167. Suppression of lymphocyte stimulation following bereavement
168. Lymphocyte function in major depressive disorder
169. Depression and immunity
170. Effect of psychosocial stress on natural killer cell activity
171. The impact of stressful life events on natural killer cells
172. Cytokine production and serum proteins in depression
173. +natural killer cells and related cytokines in major depression
174. Major depressive disorder is associated with elevated monocyte counts
175. The effects of an acute psychological stressor on cardiovascular, endocrine, and cellular immune response: A prospective study of individuals high and low in heart rate reactivity
176. Natural killer cell activity in adolescents with major depression
177. Negative affect, absorption, and immunity
178. Differentiation between major and milder acute mental stress by means of the leukocyte adhesiveness/aggregation test
179. Modulation of human natural killer cell activity by exposure to uncontrollable stress
180. Indicators of immune activation in major depression
181. Concentration and microheterogeneity glycophorms of alpha-1-acid glycoprotein in major depressive disorder
182. Changes in acute-phase proteins during lithium potentiation of antidepressants in refractory depression
183. Stress and psychosocial factors: Effects on primary cellular immune response
184. Changes in immunoglobulin, complement and acute phase protein levels in depressed patients and normal controls
185. Research diagnostic criteria: Rationale and reliability
186. Lymphocyte response in depressed patients and subjects anticipating bereavement
187. Depression, the immune system, and health and illness
188. Evidence that secretory IgA antibody is associated with daily mood
189. Effects of mental stressors on mitogen-induced lymphocyte responses in the laboratory
190. Nonsuppression of cortisol in depression and immune function
191. Measurement of cortisol and lymphocyte subpopulations in depressed and conduct-disordered adolescents
192. Slow-reacting immunoglobulin in relation to social support and changes in job strain: A preliminary note
193. T-lymphocytes in depressive disorder
194. Lytic effector cell function in schizophrenia and depression
195. Psychological stress-factors and concentrations of immunoglobulins and complement components in humans
196. Lower total serum protein, albumin, and beta- and gamma-globulin in major and treatment-resistant depression: Effects of antidepressant treatments
197. Depression and immunocompetence: A review of the literature
198. Differential effects of controllable and uncontrollable acute stress on lymphocyte proliferation and leukocyte percentages in humans
199. Cytokine production in major depressed patients before and after clomipramine treatment
200. Natural killer cytoxicity in the diagnosis of immune dysfunction: Criteria for a reproducible assay
201. T-lymphocyte polyclonal proliferation: Effects of stress and stress response style on medical students taking national board examinations
202. Stress, reactivity, and immune function in healthy men
203. Bereavement, depression, and immune function
204. Relation of stressors and depressive symptoms to clinical progression of viral illness